CSIMarket Company Name, Ticker, Competitors, else..


Cencora Inc   (NYSE: COR)
Other Ticker:  
 

Cencora Inc

COR's Fundamental analysis



Looking into Cencora Inc growth rates, revenue grew by 14.73 % in IV. Quarter 2024 from the same quarter a year ago.

Pharmacy Services & Retail Drugstore industry recorded growth of revenues by 8.79 %

Cencora Inc 's net profit decreased by -99.55 % in IV. Quarter 2024 year on year, to $7 millions.

• More on COR's Growth


Cencora Inc
current PE on trailing twelve month basis is above Pharmacy Services & Retail Drugstore industry average.

Company is currently trading with Price to Cash flow multiple of 89.01 in trailing twelve-month period. Pharmacy Services & Retail Drugstore industry recorded net loss in trailing twelve months.
Company
32.24
PE TTM   
Industry
23.69
PE TTM    
Company's Price to Sales ratio is at 0.17.
Pharmacy Services & Retail Drugstore industry's Price to Sales ratio is at 0.21.


• More on COR's Valuation
 
 Total Debt (Millions $) 4,388
 Dividend TTM ($) 2.03 $
 Dividend Yield TTM (%) 0.83 %
 Revenue/Employee (TTM) $ 6,390,404
 Net Income/Employee (TTM) $ 33,028
 Receivable Turnover (TTM) 12.76
 Tangible Book Value (Per Share $) -62.53

Cencora Inc
current PE on trailing twelve month basis is above Pharmacy Services & Retail Drugstore industry average.

Company is currently trading with Price to Cash flow multiple of 89.01 in trailing twelve-month period. Pharmacy Services & Retail Drugstore industry recorded net loss in trailing twelve months.
Company
32.24
PE TTM   
Industry
23.69
PE TTM    
Company's Price to Sales ratio is at 0.17.
Pharmacy Services & Retail Drugstore industry's Price to Sales ratio is at 0.21.

Cencora Inc Price to Book Ratio is at 61.66 lower than Industry Avg. of 1589.07. and higher than S&P 500 Avg. of 0.01

• More on COR's Valuation

•  Market Capitalization (Millions $) 48,510
•  Shares Outstanding (Millions) 200
•  Employees 46,000
•  Revenues (TTM) (Millions $) 293,959
•  Net Income (TTM) (Millions $) 1,519
•  Cash Flow (TTM) (Millions $) 545
•  Capital Exp. (TTM) (Millions $) -487
•  Total Debt (Millions $) 4,388
•  Dividend TTM ($) 2.03 $
•  Dividend Yield TTM (%) 0.83 %
•  Revenue/Employee (TTM) $ 6,390,404
•  Net Income/Employee(TTM) $ 33,028
•  Receivable Turnover Ratio (TTM) 12.76
•  Tangible Book Value (Per Share $) -62.53

•  Market Capitalization (Millions $) 48,510
•  Shares Outstanding (Millions) 200
•  Employees 46,000
•  Revenues (TTM) (Millions $) 293,959
•  Net Income (TTM) (Millions $) 1,519
•  Cash Flow (TTM) (Millions $) 545
•  Capital Exp. (TTM) (Millions $) -487


    COR's Profitability Comparisons
Cencora Inc faced margin deterioration, primarily through cost pressure. Operating Margin fell in IV. Quarter 2024 to 0.16 % from 0.91 % in III. Quarter.

Cencora Inc net profit margin of 0.01 % is currently ranking no. 6 in Pharmacy Services & Retail Drugstore industry, ranking no. 119 in Retail sector and number 2312 in S&P 500.


Profitability by Segment
Total 0.66 %
International Healthcare Solutions 8.91 %



  Ratio
•   Capital Ratio (MRQ) 0.88
•  Total Debt to Equity (MRQ) 5.58
•  Tangible Leverage Ratio (MRQ) -
•  Asset Turnover Ratio (TTM) 4.5
•  Inventory Turnover Ratio (TTM) 15.44



Cencora Inc faced margin deterioration, primarily through cost pressure. Operating Margin fell in IV. Quarter 2024 to 0.16 % from 0.91 % in III. Quarter.

Cencora Inc net profit margin of 0.01 % is currently ranking no. 6 in Pharmacy Services & Retail Drugstore industry, ranking no. 119 in Retail sector and number 2312 in S&P 500.

• More on COR's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com